Reach Us +441414719275
Horacio Pérez-Sánchez | OMICS International
ISSN: 2169-0138

Drug Designing: Open Access
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Horacio Pérez-Sánchez

Horacio Pérez-Sánchez School of Computer Science
University of Murcia,
Parallel Computer Architecture Group,


Dr. Horacio Pérez-Sánchez graduated in Theoretical and Computational Chemistry from the University of Murcia (Spain) in 1999, where he also obtained his Ph.D. degree in 2006, which consisted in the development and implementation of computational methodologies for the study of macromolecular systems. He performed research in several European Institutions such as the Institute of Structural Biology (CEA, Grenoble, France), where he successfully developed and applied computational methodologies for the prediction and interpretation of macromolecular behaviour in solution, and at the Karlsruhe Institute of Technology (Karlsruhe, Germany), where he developed new methodologies for drug discovery and implemented them in parallel architectures such as the Cell Broadband Engine, Graphics Processing Units and Supercomputers. Currently, he is full-time researcher at the School of Computer Science of the University of Murcia in the Parallel Computer Architecture Group where he works in several research lines related with the implementation and exploitation of bioinformatics methodologies in parallel architectures. Dr. Pérez-Sánchez has co-authored more than 25 conference and journal papers, book chapters and European patents. He has served as a reviewer for several conferences/journals/book editorials. His primary research interests are in the areas of Bioinformatics, mainly Drug Discovery, and its exploitation in parallel architectures. He has participated in several projects funded by the European Commission and the Spanish and German Ministries of Science.

Global Speakers in the subject

Global Experts in the subject

Leave Your Message 24x7